Last update: 29 November 2025
Compare top-rated telehealth providers offering FDA-approved weight loss medications. Get expert reviews, pricing comparisons, and find the best option for your health journey.
Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Select a category below to view detailed comparisons, reviews, and ratings
Compare weight loss injections 2025
Compare weight loss injections 2025
Our highest-rated telehealth providers for weight loss medications
Get Started Online for Just $7.99
Lose Weight Or Get Your Money Back
Get Qualified for Ozempic®, Wegovy®, or Zepbound®
No Hidden Fees
Special Offer: $120 Off with Code BWLM2025
Compounded GLP-1 Plans Available
No Waitlist, No Insurance Needed
Get Approved with Easy 2-Minute Quiz
We analyze thousands of verified user reviews, provider credentials, pricing models, and clinical data to help you make an informed decision. Whether you're looking for Ozempic®, Wegovy®, Zepbound®, or other GLP-1 medications, our detailed guides break down the top telehealth providers to help you find the right fit for your health goals and budget. Our independent research ensures you get honest, unbiased comparisons.
Important information about prescription medications and their approved uses
FDA Indications: Prescription-only subcutaneous injection indicated to improve blood sugar in adults with type 2 diabetes and to reduce certain cardiovascular risks in qualifying patients. It is not FDA-approved for weight loss, though weight loss may occur in people treated for diabetes.
FDA Indications: Prescription-only subcutaneous injection indicated, alongside a reduced-calorie diet and increased physical activity, for chronic weight management in adults with obesity or adults with overweight plus at least one weight-related condition. Also approved for chronic weight management in adolescents aged 12 and older with obesity.
FDA Indications: Prescription-only subcutaneous injection indicated, with a reduced-calorie diet and increased physical activity, for chronic weight management in adults with obesity or adults with overweight plus at least one weight-related condition. Also approved for treating moderate to severe obstructive sleep apnea in adults with obesity.
FDA Indications: Prescription-only subcutaneous injection indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. It is not indicated for weight loss.